ResMed Tops Expectations but Falls Anyway
Medical-device maker ResMed (NYSE: RMD) reported its fiscal fourth-quarter results after the market closed on Tuesday, Aug. 1. The continuous positive airway pressure (CPAP) pioneer reported modest top-line growth when compared with last quarter, but margin improvements help drive better-than-expected results on the bottom line.
Let's take a closer look at the company's results to get a better sense of how it fared during the period.
Image source: Getty Images.
Source: Fool.com
Resmed Inc. Stock
€189.90
3.540%
Resmed Inc. is currently one of the favorites of our community with 16 Buy predictions and no Sell predictions.
As a result the target price of 258 € shows a positive potential of 35.86% compared to the current price of 189.9 € for Resmed Inc..


